These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 2827218)

  • 1. Gonadal steroids do not affect basal growth hormone response to naloxone in humans.
    Monteleone P; Maj M; Iovino M; Fiorenza L; Fiumani PM; Steardo L
    Psychopharmacology (Berl); 1987; 93(2):268-70. PubMed ID: 2827218
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of sexual steroids in the modulation of growth hormone (GH) secretion in humans.
    Devesa J; Lois N; Arce V; Diaz MJ; Lima L; Tresguerres JA
    J Steroid Biochem Mol Biol; 1991; 40(1-3):165-73. PubMed ID: 1958517
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Naloxone-induced prolactin secretion in women: evidence against a direct prolactin stimulatory effect of endogenous opioids.
    Cetel NS; Quigley ME; Yen SS
    J Clin Endocrinol Metab; 1985 Jan; 60(1):191-6. PubMed ID: 3964791
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Opiate receptors and anterior pituitary hormone secretion in man. Effect of naloxone infusion.
    Delitala G; Devilla L; Arata L
    Acta Endocrinol (Copenh); 1981 Jun; 97(2):150-6. PubMed ID: 6263025
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sex-related naloxone influence on growth hormone-releasing hormone-induced growth hormone secretion in normal subjects.
    Barbarino A; De Marinis L; Mancini A; D'Amico C; Passeri M; Zuppi P; Sambo P; Tofani A
    Metabolism; 1987 Feb; 36(2):105-9. PubMed ID: 3100909
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence for increased dopaminergic and opioid activity in patients with hypothalamic hypogonadotropic amenorrhea.
    Quigley ME; Sheehan KL; Casper RF; Yen SS
    J Clin Endocrinol Metab; 1980 May; 50(5):949-54. PubMed ID: 6246138
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sex steroids, growth hormone, insulin-like growth factor-1: neuroendocrine and metabolic regulation in puberty.
    Mauras N; Rogol AD; Haymond MW; Veldhuis JD
    Horm Res; 1996; 45(1-2):74-80. PubMed ID: 8742123
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of clonidine on hormone release mediated through activation of opiate receptors.
    Baranowska B
    Cardiovasc Drugs Ther; 1990 Aug; 4(4):1113-7. PubMed ID: 1964578
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Growth hormone, prolactin and cortisol nyctohemeral variations during naloxone-induced opiate receptor blockade in man.
    Delitala G; Giusti M; Rodriguez G; Mazzocchi G; Ferrini S; Baccelliere L; Montano V; Rosadini G; Giordano G
    Acta Endocrinol (Copenh); 1982 Jul; 100(3):321-6. PubMed ID: 6287782
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of naloxone on the growth hormone response to clonidine in normal women during the mid-luteal phase.
    Phipps WR; Campbell BF; Pescovitz OH
    Psychoneuroendocrinology; 1989; 14(1-2):137-43. PubMed ID: 2543999
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of chronic stimulation or antagonism of opiate receptors on GH secretion in male and female rats.
    Simpkins JW; Millard WJ; Berglund LA
    Life Sci; 1993; 52(17):1443-50. PubMed ID: 8385257
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence for opiate and estrogen interaction on neurohormonal secretion.
    Steardo L; Monteleone P; Scopacasa F
    Acta Neurol (Napoli); 1983 Jun; 5(3):165-73. PubMed ID: 6310976
    [No Abstract]   [Full Text] [Related]  

  • 13. Sex differences in the responses of hypothalamic luteinizing hormone-releasing hormone and catecholamine systems to ovarian hormones and naloxone: implications for sexual differentiation of luteinizing hormone secretion in rats.
    Crowley WR
    Brain Res; 1988 Oct; 461(2):314-21. PubMed ID: 3052697
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Growth hormone: a regulator of the sexually differentiated steroid metabolism in rat liver.
    Gustafsson JA; Mode A; Norstedt G; Eneroth P; Hökfelt T
    Prog Clin Biol Res; 1983; 135():37-59. PubMed ID: 6665012
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endocrine actions of opioids.
    Pfeiffer A; Herz A
    Horm Metab Res; 1984 Aug; 16(8):386-97. PubMed ID: 6088380
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of naloxone and neonatal treatment with monosodium-L-glutamate on growth hormone and prolactin release induced by electrical stimulation of the medial-basal hypothalamus in rats.
    Antoni FA; Kanyicska B; Makara GB
    J Endocrinol; 1983 Mar; 96(3):427-32. PubMed ID: 6833931
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sexually dimorphic expression of the growth hormone-releasing hormone gene is not mediated by circulating gonadal hormones in the adult rat.
    Maiter D; Koenig JI; Kaplan LM
    Endocrinology; 1991 Apr; 128(4):1709-16. PubMed ID: 2004597
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of naloxone on endogenous opioid regulation of pituitary gonadotropins and prolactin during the menstrual cycle.
    Snowden EU; Khan-Dawood FS; Dawood MY
    J Clin Endocrinol Metab; 1984 Aug; 59(2):298-302. PubMed ID: 6330154
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Menstrual cycle effects on hypothalamic dopamine receptor function in women with a history of puerperal bipolar disorder.
    Wieck A; Davies RA; Hirst AD; Brown N; Papadopoulos A; Marks MN; Checkley SA; Kumar RC; Campbell IC
    J Psychopharmacol; 2003 Jun; 17(2):204-9. PubMed ID: 12870568
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Partial blockade by naloxone of clonidine-induced increase in plasma growth hormone in hypertensive patients.
    Bramnert M; Hökfelt B
    J Clin Endocrinol Metab; 1984 Feb; 58(2):374-7. PubMed ID: 6319449
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.